drugset / Trial / NCT02159547

IV Dexketoprofen vs Placebo in Migranie Attack

NCT02159547

Phase 4 Completed 224 enrolled Akdeniz University
RandomizedParallel-groupDouble-blindTreatment

Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

Timeline

Start
2014-05
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexketoprofen Small molecule 50 mg

Indications